JCS2024
@JCS2024_tweets
JCS2024 will invite up-and-coming researchers under the theme "Cytokine Physiology and Pathology" and provide a forum to discuss cutting-edge topics in Sapporo!
JCS2024 will be held in a hybrid, on-demand format. We look forward to your participation!!!
There will be also six sessions (organizers: Drs. Akihiko Yoshimura, Ken J Ishii, Osamu Takeuchi, Kiyoshi Takeda, Keishi Fujio, and Hiroshi Takayanagi), oral and poster sessions, and lunch seminars organized by Thermo Fisher Scientific to discuss cutting-edge research.
We will welcome Dr. Tadamitsu Kishimoto (Osaka U.), who was involved in the discovery of IL-6 and its clinical application, and Dr. Tadatsugu Taniguchi (U. of Tokyo), who discovered interferon-β and IL-2 and elucidated their mechanisms of action and roles, as keynote speakers!
These two societies were closely related in terms of mutual personnel exchange and research targets in the academic field of immunology. JCS2024 will be the first academic conference after their merger.
The JCS was established in FY2023 through the merger of two academic societies: the Japanese Society for Interferon and Cytokine Research (JSICR) and the Japanese Society of Molecular Cell Biology of Macrophages (MMCB).
